Ahmedabad, India

Parind Narendra Dholakia

USPTO Granted Patents = 3 


Average Co-Inventor Count = 4.1

ph-index = 1


Location History:

  • Ahmedabad, IN (2011)
  • Gujarat, IN (2011 - 2014)

Company Filing History:


Years Active: 2011-2014

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Parind Narendra Dholakia: Innovator in Pharmaceutical Processes

Introduction

Parind Narendra Dholakia is a prominent inventor based in Ahmedabad, India. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of various forms of Clopidogrel compounds. With a total of 3 patents to his name, Dholakia's work has had a notable impact on the medical industry.

Latest Patents

Dholakia's latest patents include innovative processes for preparing different forms of (S)-(+)-Clopidogrel bisulfate. This invention provides improved methods for the preparation of the hydrated form of (S)-(+)-Clopidogrel bisulfate, as well as enhanced processes for the preparation of form-I and form-II of the compound. Additionally, he has developed processes for the preparation of different forms of (S)-(+)-Clopidogrel besylate. These patents disclose improved methods for creating various forms of (S)-(+)-Clopidogrel besylate, along with pharmaceutical compositions containing them and their applications in medicine.

Career Highlights

Dholakia is currently associated with Cadila Healthcare Limited, a leading pharmaceutical company in India. His work at Cadila has allowed him to focus on innovative pharmaceutical processes that contribute to the development of effective medications.

Collaborations

Some of his notable coworkers include Mayank Ghanshyambhai Dave and Braj Bhushan Lohray. Their collaboration has fostered an environment of innovation and excellence in pharmaceutical research.

Conclusion

Parind Narendra Dholakia's contributions to the pharmaceutical industry through his patents and innovative processes highlight his role as a key inventor in the field. His work continues to influence the development of important medical compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…